Overview

PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This trial will be conducted to explore the biological effects in the skin following treatment with PEP005 Gel, 0.05% administered for two consecutive days, assessed by reflectance confocal microscopy.
Phase:
Phase 1
Details
Lead Sponsor:
LEO Pharma